SEC Comment Letter for TENAX THERAPEUTICS, INC. (TENX) (CIK 0000034956) (TENX) — Mar 29, 2010

TENAX THERAPEUTICS, INC. (TENX) (CIK 0000034956)
Date: March 29, 2010 · CIK: 0000034956 · Accession: 0000000000-10-017116

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

March 26, 2010

Author

Gus Rodriguez

Form

UPLOAD

Company

TENAX THERAPEUTICS, INC. (TENX) (CIK 0000034956)

Letter

Via Facsimile and U.S. Mail Mail Stop 4720 March 26, 2010 Mr. Chris J. Stern Chief Executive Officer Oxygen Biotherapeutics, Inc. 2530 Meridian Parkway, Suite 3084 Durham, North Carolina 27713 Re: Oxygen Biotherapeutics, Inc. Form 10-K for the Fiscal Year Ended April 30, 2009 File No. 002-31909 Dear Mr. Stern:

We have completed our review of your Fo rm 10-K and related filings and have no further comments at this time. Sincerely,

Gus Rodriguez Accounting Branch Chief

Show Raw Text

Via Facsimile and U.S. Mail Mail Stop 4720                                                                                                      March 26, 2010   Mr. Chris J. Stern Chief Executive Officer  Oxygen Biotherapeutics, Inc.    2530 Meridian Parkway, Suite 3084 Durham, North Carolina 27713
Re: Oxygen Biotherapeutics, Inc.
 Form 10-K for the Fiscal Year Ended April 30, 2009
File No. 002-31909
 Dear Mr. Stern:

We have completed our review of your Fo rm 10-K and related filings and have no
further comments at this time.
 Sincerely,

Gus Rodriguez Accounting Branch Chief

SecProbe.io